Mucolytic vs placebo
Participants with no exacerbations in study period · chronic bronchitis or COPD
Mucolytic probably leads to higher participants with no exacerbations in study period compared with placebo (moderate certainty).
1 finding from 1 review
- Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes onlyPeto OR 1.73 [1.56, 1.91]28 studies · 6723 participantsModerate